NCT00214032View on ClinicalTrials.gov

Pycnogenol for the Treatment of Lymphedema

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

November 30, 2006

Study Completion Date

January 31, 2007

Conditions
Lymphedema
Interventions
DRUG

Pycnogenol

pycnogenol 300 mg daily

DRUG

Placebo

placebo 3 capsules daily

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00214032 - Pycnogenol for the Treatment of Lymphedema | Biotech Hunter | Biotech Hunter